Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura D'Alimonte

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 24, 2017
Stereotactic ablative radiotherapy in the treatment of low and intermediate risk prostate cancer: Is there an optimal dose?Joelle Helou, Laura D'Alimonte, Harvey Quon, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 25, 2013
Opinions from the experts: exploring what prostate cancer patients should know about post-operative radiotherapyLaura D'Alimonte, Kaitlin Koo, Emily Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 16, 2015
High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of successJoelle Helou, Laura D'Alimonte, Andrew Loblaw, et al.
Practical Radiation Oncology|January 14, 2018
To prep or not to prep - that is the question: A randomized trial on the use of antiflatulent medication as part of bowel preparation for patients having image guided external beam radiation therapy to the prostateMerrylee McGuffin, Naila Devji, Lyann Kehoe, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2018
Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical TrialJure Murgic, Gerard Morton, Andrew Loblaw, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2014
A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boostJoelle Helou, Gerard Morton, Liying Zhang, et al.
Brachytherapy|December 15, 2017
Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapyAlexandru Nicolae, Jure Murgic, Ivan Kruljac, et al.
Journal of Medical Imaging and Radiation Sciences|February 20, 2019
It Only Takes a Minute: The Development and Implementation of a Patient Experience Survey in Radiation TherapyFatima Hashmi, Nikolaus Gregor, Brian Liszewski, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 9, 2016
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5GyGerard Morton, Hans T Chung, Merrylee McGuffin, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2018
Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of LifeHima Bindu Musunuru, Laura D'Alimonte, Melanie Davidson, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 24, 2017
Stereotactic ablative radiotherapy in the treatment of low and intermediate risk prostate cancer: Is there an optimal dose?Joelle Helou, Laura D'Alimonte, Harvey Quon, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 25, 2013
Opinions from the experts: exploring what prostate cancer patients should know about post-operative radiotherapyLaura D'Alimonte, Kaitlin Koo, Emily Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 16, 2015
High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of successJoelle Helou, Laura D'Alimonte, Andrew Loblaw, et al.
Practical Radiation Oncology|January 14, 2018
To prep or not to prep - that is the question: A randomized trial on the use of antiflatulent medication as part of bowel preparation for patients having image guided external beam radiation therapy to the prostateMerrylee McGuffin, Naila Devji, Lyann Kehoe, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2018
Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical TrialJure Murgic, Gerard Morton, Andrew Loblaw, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2014
A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boostJoelle Helou, Gerard Morton, Liying Zhang, et al.
Brachytherapy|December 15, 2017
Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapyAlexandru Nicolae, Jure Murgic, Ivan Kruljac, et al.
Journal of Medical Imaging and Radiation Sciences|February 20, 2019
It Only Takes a Minute: The Development and Implementation of a Patient Experience Survey in Radiation TherapyFatima Hashmi, Nikolaus Gregor, Brian Liszewski, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 9, 2016
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5GyGerard Morton, Hans T Chung, Merrylee McGuffin, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2018
Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of LifeHima Bindu Musunuru, Laura D'Alimonte, Melanie Davidson, et al.
Pageof 5